ストックスクリーナーアプリを入手
19.20
1.69%
-0.33
アフターアワーズ：
19.30
0.10
+0.52%
前日終値:
$19.53
開ける：
$19.28
24時間の取引高:
230.37K
Relative Volume:
1.04
時価総額：
$343.10M
収益：
$116.88M
当期純損益:
$-25.09M
株価収益率:
-137.14
EPS:
-0.14
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
+1.32%
1か月 パフォーマンス:
-1.84%
6か月 パフォーマンス:
-30.46%
1年 パフォーマンス:
+105.02%
1日の値動き範囲:
$18.63
$19.50
1週間の範囲:
$18.50
$19.91
52週間の値動き範囲:
$7.4843
$29.82
Rigel Pharmaceuticals Stock (RIGL) Company Profile
名前
Rigel Pharmaceuticals
セクター
電話
650-624-1100
住所
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
19.20 | 338.68M | 116.88M | -25.09M | -20.74M | -0.14 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-04-03 | 再開されました | Piper Sandler | Neutral |
| 2022-06-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-06-08 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 開始されました | B. Riley Securities | Neutral |
| 2020-11-09 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 再開されました | JP Morgan | Overweight |
| 2019-03-01 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 開始されました | Citigroup | Buy |
| 2018-05-02 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 再開されました | Piper Jaffray | Overweight |
| 2017-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 再開されました | H.C. Wainwright | Buy |
| 2017-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-31 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-30 | 繰り返されました | Piper Jaffray | Overweight |
| 2016-07-13 | 開始されました | H.C. Wainwright | Buy |
| 2016-06-13 | 開始されました | Piper Jaffray | Overweight |
| 2016-04-22 | アップグレード | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 繰り返されました | Stifel | Buy |
| 2012-11-29 | 開始されました | UBS | Neutral |
| 2012-11-06 | 繰り返されました | Oppenheimer | Outperform |
| 2012-03-26 | 開始されました | Canaccord Genuity | Hold |
| 2010-12-10 | ダウングレード | MP Advisors | Outperform → Market Perform |
すべてを表示
Rigel Pharmaceuticals (RIGL) 最新ニュース
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance
Rigel to Present at the Jefferies Global Healthcare Conference - Kilgore News Herald
Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow
Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise
Rigel to Present at the Jefferies Global Healthcare Conference | - GuruFocus
(RIGL) Proactive Strategies - news.stocktradersdaily.com
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire
Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World
(RIGL) Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now? - Yahoo Finance
Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet - MSN
Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts - Yahoo Finance
Wells Fargo & Company MN Buys 2,648 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Cantor Fitzgerald Brokers Reduce Earnings Estimates for RIGL - Defense World
B. Riley Expects Reduced Earnings for Rigel Pharmaceuticals - Defense World
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
Earnings Estimates Rising for Rigel (RIGL): Will It Gain? - Yahoo Finance
MetLife Investment Management LLC Acquires 2,014 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Rigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performance - MSN
Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
HC Wainwright Issues Positive Outlook for RIGL Earnings - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2025 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of “Hold” by Analysts - Defense World
Rigel Pharmaceuticals Reports Strong Growth and Strategic Advances - TipRanks
Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals (RIGL) Price Target Raised by Cantor Fitzg - GuruFocus
Earnings call transcript: Rigel Pharmaceuticals sees stock surge after Q1 2025 earnings - Investing.com Nigeria
Jefferies cuts Rigel stock target to $20.45, maintains hold - Investing.com
Earnings call transcript: Rigel Pharmaceuticals sees stock surge after Q1 2025 earnings By Investing.com - Investing.com South Africa
Rigel Pharma Jump 9.9% Premarket; Guides 'Positive' Net Income in 2025 After Swinging to Profit in Q1 - marketscreener.com
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlight - GuruFocus
Rigel Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks
Rigel: Q1 Earnings Snapshot - CTPost
Rigel Pharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals reports Q1 EPS 63c vs. 47c last year - TipRanks
Rigel Pharmaceuticals reaffirms FY25 revenue $200M-$210M, consensus $197.79M - TipRanks
Rigel Pharmaceuticals (RIGL) Surpasses Q1 Revenue Expectations | - GuruFocus
Rigel Pharmaceuticals (RIGL) 財務データ
収益
当期純利益
現金流量
EPS
1.89%
3.74%
大文字化:
|
ボリューム (24 時間):